Ácido nucleico antisentido que induce la omisión del exón 50

La presente especificación proporciona un fármaco que provoca el salto altamente eficiente de exón 50 en el gen de distrofina humana. La presente especificación proporciona un oligómero antisentido que induce el salto de exón 50 en el gen de distrofina humana. The present specification provides a dr...

Full description

Saved in:
Bibliographic Details
Main Authors ENYA, Yukiko, WAKI, Reiko, AOKI, Yoshitsugu, SUNADOI, Yuta, TAKEDA, Shin'ichi, MUCHIMA, Kaname
Format Patent
LanguageSpanish
Published 19.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract La presente especificación proporciona un fármaco que provoca el salto altamente eficiente de exón 50 en el gen de distrofina humana. La presente especificación proporciona un oligómero antisentido que induce el salto de exón 50 en el gen de distrofina humana. The present specification provides a drug that causes highly-efficient skipping of exon 50 in the human dystrophin gene. The present specification provides an antisense oligomer which induces skipping of exon 50 in the human dystrophin gene.
AbstractList La presente especificación proporciona un fármaco que provoca el salto altamente eficiente de exón 50 en el gen de distrofina humana. La presente especificación proporciona un oligómero antisentido que induce el salto de exón 50 en el gen de distrofina humana. The present specification provides a drug that causes highly-efficient skipping of exon 50 in the human dystrophin gene. The present specification provides an antisense oligomer which induces skipping of exon 50 in the human dystrophin gene.
Author ENYA, Yukiko
MUCHIMA, Kaname
SUNADOI, Yuta
AOKI, Yoshitsugu
TAKEDA, Shin'ichi
WAKI, Reiko
Author_xml – fullname: ENYA, Yukiko
– fullname: WAKI, Reiko
– fullname: AOKI, Yoshitsugu
– fullname: SUNADOI, Yuta
– fullname: TAKEDA, Shin'ichi
– fullname: MUCHIMA, Kaname
BookMark eNrjYmDJy89L5WSwP9yYnJmSr5BXmpyTmpmcr5CYV5JZnAokgIKFpakKmXkppcmpCjmJCvm5mcWZhzfnKaSk5iikVoBYpgY8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSTe2d_IwMjIwMDCzMzE0ciYOFUAAcU0kQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CO2022008664A2
GroupedDBID EVB
ID FETCH-epo_espacenet_CO2022008664A23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:49:51 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CO2022008664A23
Notes Application Number: CO20220008664
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220719&DB=EPODOC&CC=CO&NR=2022008664A2
ParticipantIDs epo_espacenet_CO2022008664A2
PublicationCentury 2000
PublicationDate 20220719
PublicationDateYYYYMMDD 2022-07-19
PublicationDate_xml – month: 07
  year: 2022
  text: 20220719
  day: 19
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
NIPPON SHINYAKU CO., LTD
RelatedCompanies_xml – name: NIPPON SHINYAKU CO., LTD
– name: NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
Score 3.2565832
Snippet La presente especificación proporciona un fármaco que provoca el salto altamente eficiente de exón 50 en el gen de distrofina humana. La presente...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Ácido nucleico antisentido que induce la omisión del exón 50
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220719&DB=EPODOC&locale=&CC=CO&NR=2022008664A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRZUHJLWjzJIdQ7CahCG2KVOmtZLcjBEJSTESv_iZ_Qv-YszHVnnrbBwz7-ua1O7MAt6bpCRdtqbw26gsz6egeAUNHOk8LI0GRCBXgPBo7w2frcWbPWpCtY2HqPKEfdXJEQpQkvFc1v17-O7GC-m1leSdSair60dQPtMY6NgySmJ4WDPxwEgcx1zj3eayNn377SH13rAdi2DukSLsKD-HLQMWlLDeFSnQIuxOil1dH0MKyA_t8_fdaB_ZGzZU3FRv0lcfQX33JdFGwXOUgph1ktCqpCh5SjcTfGdnXtFMsS1hBlNLVd84WmDH8VCX7_gRuonDKhzqNZP438TmPN4dtnkI7L3I8A4Y9NFz3VRpS6TOCmKeJFhkKiIZn2457Dt1tlC62d1_CgaoqD2bP60K7envHKxK9lbiuV-wHPRuIgQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-Kj6oKSW9EmTUIOodhNQtQmKVKlt9CkIwRCUkxEr_4mf0L_mLMx1Z56W3Zg2Nc3r92ZBbhWFCPSUY1F1EZ8YRZrXYOA0UU6T3N5htEsEgnOnq-5z_2HqTptQLrKhanqhH5UxREJUTHhvazk9eI_iGVVbyuLmyihrnzgTExLqr1jWSaNaUjW0LTHgRVwiXOTB5L_9Esj813r35HA3iIjWxd4sF-GIi9lsa5UnD3YHhO_rNyHBhZtaPHV32tt2PHqK29q1ugrDmCw_IqTec4yUYOYdpDRqiQieUh0knxn5F_TTrF0xnLilCy_MzbHlOGnaKm3h3Dl2BPudmkk4d_EQx6sD1s5gmaWZ3gMDHso6_prLMfCnolIeCrYJ0cBUTZUVdNPoLOJ0-lm8iW03Ik3Ckf3_uMZ7AqSiGb2jA40y7d3PCc1XEYX1er9AM99i3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%C3%81cido+nucleico+antisentido+que+induce+la+omisi%C3%B3n+del+ex%C3%B3n+50&rft.inventor=ENYA%2C+Yukiko&rft.inventor=WAKI%2C+Reiko&rft.inventor=AOKI%2C+Yoshitsugu&rft.inventor=SUNADOI%2C+Yuta&rft.inventor=TAKEDA%2C+Shin%27ichi&rft.inventor=MUCHIMA%2C+Kaname&rft.date=2022-07-19&rft.externalDBID=A2&rft.externalDocID=CO2022008664A2